Literature DB >> 12110891

Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.

Tian H Chi1, Mimi Wan, Keji Zhao, Ichiro Taniuchi, Lei Chen, Dan R Littman, Gerald R Crabtree.   

Abstract

Thymic development produces two sub-lineages of T cells expressing either CD4 or CD8 co-receptors that assist antibody production and mediate cell killing, respectively. The mechanisms for mutually exclusive co-receptor expression remain poorly defined. We find that mutations in the high mobility group (HMG) domain of BAF57--a DNA-binding subunit of the mammalian SWI/SNF-like chromatin-remodelling BAF complexes--or in the BAF complex ATPase subunit Brg, impair both CD4 silencing and CD8 activation. Brg is haploinsufficient for CD8 activation, but not for CD4 silencing, whereas BAF57 mutations preferentially impair CD4 silencing, pointing to target- and subunit-specific mechanisms of chromatin remodelling. BAF complexes directly bind the CD4 silencer, but the BAF57 HMG domain is dispensable for tethering BAF complexes to the CD4 silencer or other chromatin loci in vivo, or for remodelling reconstituted templates in vitro, suggesting that chromatin remodelling in vivo requires HMG-dependent DNA bending. These results indicate that BAF complexes contribute to lineage bifurcation by reciprocally regulating lineage-specific genes, reminiscent of the role of the yeast SWI/SNF complex in mediating mating-type switching.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110891     DOI: 10.1038/nature00876

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

Review 1.  Priming the nucleosome: a role for HMGB proteins?

Authors:  Andrew A Travers
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

2.  The nuclear actin-related proteins Arp7 and Arp9: a dimeric module that cooperates with architectural proteins for chromatin remodeling.

Authors:  Heather Szerlong; Anjanabha Saha; Bradley R Cairns
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

3.  Identification of a polymorphic, neuron-specific chromatin remodeling complex.

Authors:  Ivan Olave; Weidong Wang; Yutong Xue; Ann Kuo; Gerald R Crabtree
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

Review 4.  Transcriptional control of thymocyte positive selection.

Authors:  Gilbert J Kersh
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression.

Authors:  Fuhua Xu; Stephen Flowers; Elizabeth Moran
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

6.  Ikaros SUMOylation: switching out of repression.

Authors:  Pablo Gómez-del Arco; Joseph Koipally; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Authors:  Kevin A Link; Craig J Burd; Erin Williams; Thomas Marshall; Gary Rosson; Erin Henry; Bernard Weissman; Karen E Knudsen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

9.  Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3.

Authors:  Merav Yarmus; Eilon Woolf; Yael Bernstein; Ofer Fainaru; Varda Negreanu; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

10.  A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription.

Authors:  Nickolai A Barlev; Alexander V Emelyanov; Paola Castagnino; Philip Zegerman; Andrew J Bannister; Manuel A Sepulveda; Flavie Robert; Laszlo Tora; Tony Kouzarides; Barbara K Birshtein; Shelley L Berger
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.